Poor prognosis acute myelogenous leukemia 2 — biological and molecular biological characteristics and treatment outcome

Biological and molecular biological studies were performed on the marrow cells of 25 patients with poor prognosis AML to both characterize this type of leukemia and to assess the relationship between the parameters which were measured and treatment outcome. Treatment failure associated with high lev...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia research 2000-09, Vol.24 (9), p.777-789
Hauptverfasser:	Li, Biarou, Yang, Jie, Tao, Ming, Nayini, Jaya, Horvath, Erzsebet, Chopra, Harpareet, Meyer, PeterM, Venugopal, Paramesaran, Preisler, Harvey D
Format:	Artikel
Sprache:	eng
Schlagworte:	Amifostine Amifostine - therapeutic use AML Antineoplastic agents Base Sequence Biological and medical sciences Chemotherapy Cytokines DNA Primers Humans Leukemia, Myeloid, Acute - pathology Medical sciences Pharmacology. Drug treatments Prognosis Remission induction Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!